{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:37:30Z","timestamp":1764700650582},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1994,8,1]],"date-time":"1994-08-01T00:00:00Z","timestamp":775699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1994,8,1]],"date-time":"1994-08-01T00:00:00Z","timestamp":775699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[1994,8]]},"DOI":"10.1093\/ajcn\/60.2.153","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T20:48:53Z","timestamp":1515185333000},"page":"153-156","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Report on the NIH Workshop on Pharmacologic Treatment of Obesity"],"prefix":"10.1016","volume":"60","author":[{"given":"RL","family":"Atkinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VS","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1093\/ajcn\/60.2.153_bib1","doi-asserted-by":"crossref","first-page":"495S","DOI":"10.1093\/ajcn\/55.2.495s","article-title":"Prevalence of overweight and weight gain in the United States","volume":"55","author":"Kuczmarski","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/60.2.153_bib2","first-page":"303","article-title":"Relative weight classifications in the assessment of underweight and overweight in the United States","volume":"16","author":"Sichieri","year":"1992","journal-title":"Int J Obes"},{"issue":"suppl","key":"10.1093\/ajcn\/60.2.153_bib3","doi-asserted-by":"crossref","first-page":"503S","DOI":"10.1093\/ajcn\/55.2.503s","article-title":"Economic costs of obesity","volume":"55","author":"Colditz","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/60.2.153_bib4","series-title":"Obesity in America","author":"Bray","year":"1979"},{"issue":"suppl","key":"10.1093\/ajcn\/60.2.153_bib5","first-page":"615S","article-title":"Consensus Development Conference Statement on Gastrointestinal Surgery for Severe Obesity","volume":"55","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/60.2.153_bib6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.7326\/0003-4819-116-11-942","article-title":"Methods for voluntary weight loss and control","volume":"116","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1093\/ajcn\/60.2.153_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/0003-4819-115-2-152","article-title":"Barriers to the treatment of obesity","volume":"115","author":"Bray","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1093\/ajcn\/60.2.153_bib8","first-page":"441","article-title":"Review of amphetamine-like drugs by the Food and Drug Administration Obesity in perspective. Fogarty International Center for Advanced Studies in the Health Sciences, Series on Preventive Medicine","volume":"2","author":"Scoville","year":"1976"},{"key":"10.1093\/ajcn\/60.2.153_bib9","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(89)91499-2","article-title":"International trial of long-term dexfenfluramine in obesity","volume":"2","author":"Guy-Grand","year":"1989","journal-title":"Lancet"},{"issue":"suppl","key":"10.1093\/ajcn\/60.2.153_bib10","doi-asserted-by":"crossref","first-page":"189S","DOI":"10.1093\/ajcn\/55.1.189s","article-title":"Appraisal of the clinical value of serotoninergic drugs","volume":"55","author":"Munro","year":"1992","journal-title":"Am J Clin Nutr"},{"issue":"suppl 2","key":"10.1093\/ajcn\/60.2.153_bib11","first-page":"91","article-title":"Prolonged use of a very low calorie diet (Cambridge diet) in massively obese patients attending an obesity clinic: safety, efficacy and additional benefit from dexfenfluramine","volume":"13","author":"Finer","year":"1989","journal-title":"Int J Obes"},{"issue":"suppl 3","key":"10.1093\/ajcn\/60.2.153_bib12","first-page":"S25","article-title":"Body weight evolution during dexfenfluramine treatment after initial weight control","volume":"16","author":"Finer","year":"1992","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.2.153_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1464-5491.1992.tb01793.x","article-title":"The effects of dexfenfluramine on blood glucose control in patients with type 2 diabetes","volume":"9","author":"Willey","year":"1992","journal-title":"Diabet Med"},{"key":"10.1093\/ajcn\/60.2.153_bib14","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2165\/00003495-199243060-00003","article-title":"Appetite suppressants: a review","volume":"43","author":"Silverstone","year":"1992","journal-title":"Drugs"},{"key":"10.1093\/ajcn\/60.2.153_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/1098-108X(198711)6:6<687::AID-EAT2260060602>3.0.CO;2-O","article-title":"Fenfluramine suppresses snack intake among carbohydrate cravers but not among non-carbohydrate cravers","volume":"6","author":"Wurtman","year":"1987","journal-title":"Int J Eating Disorders"},{"key":"10.1093\/ajcn\/60.2.153_bib16","first-page":"91","article-title":"The acute effect of dexfenfluramine on resting metabolic rate and postprandial thermogenesis in obese subjects: a double-blind placebo- controlled study","volume":"17","author":"Scalfi","year":"1993","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.2.153_bib17","first-page":"613","article-title":"The effect of long-term dexfenfluramine treatment on 24-hr energy expenditure in man","volume":"14","author":"Breum","year":"1990","journal-title":"A double-blind placebo controlled study. Int J Obes"},{"key":"10.1093\/ajcn\/60.2.153_bib18","first-page":"581","article-title":"Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin PharmacolTher"},{"key":"10.1093\/ajcn\/60.2.153_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1992.69","article-title":"Long-term weight control study I (weeks 0 to 34)","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/60.2.153_bib20","first-page":"595","article-title":"Long-term weight control study II (weeks 34 to 104)","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin PharmacolTher"},{"key":"10.1093\/ajcn\/60.2.153_bib21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/clpt.1992.71","article-title":"Long-term weight control study III (weeks 104 to 156)","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/60.2.153_bib22","first-page":"608","article-title":"Long-term weight control study IV (weeks 156 to 190)","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin PharmacolTher"},{"key":"10.1093\/ajcn\/60.2.153_bib23","first-page":"615","article-title":"Long-term weight control study V (weeks 190 to 210)","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin PharmacolTher"},{"key":"10.1093\/ajcn\/60.2.153_bib24","first-page":"619","article-title":"Long-term weight control study VI","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin PharmacolTher"},{"key":"10.1093\/ajcn\/60.2.153_bib25","first-page":"634","article-title":"Long-term weight control study VII (weeks 0 to 210): serum lipid changes","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin PharmacolTher"},{"key":"10.1093\/ajcn\/60.2.153_bib26","first-page":"642","article-title":"Long-term weight control study: conclusions","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin PharmacolTher"},{"issue":"suppl 1","key":"10.1093\/ajcn\/60.2.153_bib27","first-page":"S35","article-title":"Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis","volume":"17","author":"Dulloo","year":"1993","journal-title":"Int J Obes"},{"issue":"suppl 1","key":"10.1093\/ajcn\/60.2.153_bib28","first-page":"S69","article-title":"Safety and efficacy of long-term treatment with ephedrine, caffeine, and an ephedrine\/caf- feine mixture","volume":"17","author":"Toubro","year":"1993","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.2.153_bib29","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/0024-3205(82)90445-3","article-title":"Anorectic agents lower a body weight set point","volume":"30","author":"Stunkard","year":"1982","journal-title":"Life Sci"},{"key":"10.1093\/ajcn\/60.2.153_bib30","first-page":"119","article-title":"The effect of a new \u00df-adrenoceptor agonist BRL 26830A in refractory obesity","volume":"12","author":"Chapman","year":"1988","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/60.2.153_bib31","doi-asserted-by":"crossref","first-page":"258S","DOI":"10.1093\/ajcn\/55.1.258s","article-title":"Clinical studies with the (3- adrenoceptor agonist BRL 26830A","volume":"55","author":"Connacher","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/60.2.153_bib32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/edrv-8-3-256","article-title":"Neuropeptide regulation of appetite and weight","volume":"8","author":"Morley","year":"1987","journal-title":"Endocrinol Rev"},{"key":"10.1093\/ajcn\/60.2.153_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00010","article-title":"Proposed standards for judging success of the treatment of obesity","volume":"119","author":"Atkinson","year":"1993","journal-title":"Ann Int Med"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523183985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523183985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/60\/2\/153\/24114165\/153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:24:36Z","timestamp":1718407476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523183985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,8]]}},"alternative-id":["S0002916523183985"],"URL":"https:\/\/doi.org\/10.1093\/ajcn\/60.2.153","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[1994,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Report on the NIH Workshop on Pharmacologic Treatment of Obesity","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/ajcn\/60.2.153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1994 American Society for Nutrition. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}